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Abstract
Background: Previously, we identified a set of HLA-A020.1-restricted trans-sialidase peptides as targets of CD8
+ T cell
responses in HLA-A0201
+ individuals chronically infected by T. cruzi.
Methods and Findings: Herein, we report the identification of peptides encoded by the same trans-sialidase gene family
that bind alleles representative of the 6 most common class I HLA-supertypes. Based on a combination of bioinformatic
predictions and HLA-supertype considerations, a total of 1001 epitopes predicted to bind to HLA A01, A02, A03, A24, B7 and
B44 supertypes was selected. Ninety-six supertype-binder epitopes encoded by multiple trans-sialidase genes were tested
for the ability to stimulate a recall CD8
+ T cell response in the peripheral blood from subjects with chronic T. cruzi infection
regardless the HLA haplotype. An overall hierarchy of antigenicity was apparent, with the A02 supertype peptides being the
most frequently recognized in the Chagas disease population followed by the A03 and the A24 supertype epitopes. CD8
+ T
cell responses to promiscuous epitopes revealed that the CD8
+ T cell compartment specific for T. cruzi displays a functional
profile with T cells secreting interferon-c alone as the predominant pattern and very low prevalence of single IL-2-secreting
or dual IFN-c/IL-2 secreting T cells denoting a lack of polyfunctional cytokine responses in chronic T. cruzi infection.
Conclusions: This study identifies a set of T. cruzi peptides that should prove useful for monitoring immune competence
and changes in infection and disease status in individuals with chronic Chagas disease.
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Introduction
Trypanosoma cruzi, the causative agent of Chagas disease,
constitutes a prominent human health problem in Central and
South America [1]. It is estimated that approximately 4 million
individuals have chagasic heart disease, making Chagas disease the
most frequent cause of infectious cardiomyopathy in the world [2].
Immune control of T. cruzi is complex, requiring the generation
of a substantial antibody response and the activation of both CD4
+
and CD8
+ T cell responses. The intracellular replication and
localization of T. cruzi have focused attention on CD8
+ T cell
responses as a critical component of protective immunity in T.
cruzi infection [3,4]. Even in cases in which such responses are
stimulated sufficiently to control the acute infection, T. cruzi is not
completely cleared but instead, persists in infected hosts for
decades. The inflammatory responses that such persistence
induces may eventually result in the tissue damage that is
associated with chronic Chagas disease [5,6]. Supporting the
hypothesis that disease is less severe when immune control is more
efficient we have shown that chronic chagasic subjects with no or
mild clinical disease have significantly higher frequency of
interferon-gamma (IFN-c) producing T cells specific for T. cruzi
than do individuals with more severe disease [7,8]. This apparent
impairment in CD8
+ T cell responses was associated with an
increased frequency of fully differentiated memory
(CD27
2CD28
2CD45RA
2) CD8
+ T cells and a high rate of
apoptosis, possibly reflecting exhaustion in the CD8
+ T cell
compartment [8]. The loss of parasite-specific T cell responses
during chronic infection, together with the diversity of HLA types
and the diversity of parasite strains and thus epitope expression,
have made it difficult to identify the specific epitopes recognized by
T. cruzi-specific CD8
+ T cells, and therefore to quantify the
response and function of parasite-specific CD8
+ T cells from
chronic chagasic individuals.
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which pathogen epitopes are primarily targeted by T cell responses,
including the nature of the restricting MHC allele, efficiency of
epitope processing and translocation into the endoplasmatic
reticulum, the degree of sequence variability in epitopes derived
from highly variable pathogens and antigen availability by either
cross-presentationof exogenousantigen orprocessingofintracellular
proteins [9–11]. In addition, interactions among different T cell
populations and cross-reactivity between ‘‘self’’ and/or ‘‘other’’
pathogen antigens, as well as the presence of antagonistic epitopes,
may further impact immunodominance patterns [12].
Trans-sialidases (ts) are a large family of surface molecules (1430
genes annotated [13]) previously shown to be the targets of
antibody responses [14–17], CD4
+ T cells [18–20] as well as CD8
+
T cells in mice [19–22] and in humans with chronic T. cruzi
infection [7,23–25]. We have recently reported on a large-scale
screen for dominant parasite peptides recognized by CD8
+ T cells
in T. cruzi infected mice, showing that the CD8
+ T cell response is
highly focused on epitopes encoded by members of the large ts
family of genes [25]. Contrasting with the mouse system, a lower
and more diffuse pattern of CD8
+ T cell responses specific for
HLA-A0201-restricted ts peptides in human subjects was found
[25]. An additional complication of translating the results of
studies in mice to the assay of human T cell responses is the large
degree of polymorphism of human HLA alleles and the
requirement to HLA-type each individual subject prior to
attempting to measure T cell responses.
Class I molecules can be grouped based upon structural
similarities, into sets (supertypes) with similar predicted binding
motifs; nine such supertypes have been defined to date [26]. The
six most common HLA supertypes cover one or more HLA allele
in .95 of a human population, irrespective of ethnicity [26,27].
Thus, by defining a set of pathogen peptides that are presented by
these six HLA supertypes, one can screen T cell responses in a
majority of individuals without having to conduct HLA typing and
tailoring the peptide set to the individual HLA type [28,29].
The present study was conducted to extend the identification of
immunodominant CD8
+ T cell epitopes in T. cruzi by searching
promiscuous HLA-Class I epitopes from ts proteins based on
HLA-supertype binding predictions and the frequency of repre-
sentation of the peptides in the predicted T. cruzi proteome, and to
investigate the functional phenotype of T cells from chronic
Chagas disease patients in response to the selected peptides.
This analysis provided the preciseidentity and promiscuity of a set
of new ts epitopes based upon binding to the 6 most common class I
HLA-supertypes. The simultaneous assessment of IFN-c and IL-2
production after stimulation with ts-derived peptides, demonstrates
thattheCD8
+ T cell compartment specificfor T.cruzi displaysa very
low level of polyfunctional cytokine responses with a predominance
of T cells secreting IFN-c alone and very low prevalence of single IL-
2-secreting or dual IFN-c/IL-2 secreting T cells.
Materials and Methods
Selection of study population
T. cruzi-infected adults volunteers aged 29 to 61 were recruited
at the Chagas disease Section of the Cardiology Department,
Hospital Interzonal General de Agudos ‘‘Eva Pero ´n’’, Buenos
Aires, Argentina. These individuals were originally infected while
living in areas endemic for T. cruzi but had lived in this non-
endemic area for a minimum of 15 years. Signed informed consent
was obtained from all individuals prior to inclusion in the study. T.
cruzi infection was determined by indirect immunofluorescence
assay, hemagglutination, and ELISA techniques [30]. Chronic
chagasic subjects were evaluated clinically and grouped according
to the Kuschnir grading system [31]. Group 0 (G0, n=37; mean
age6SD=4668 y) included seropositive individuals exhibiting a
normal electrocardiography (ECG), and a normal chest-X ray;
group 1 (G1, n=8; mean age6SD=5062 y) seropositive patients
had a normal chest-x ray but abnormalities in the ECG; group 2
(G2, n=6; mean age6SD=4869 y) seropositive patients had
ECG abnormalities and heart enlargement as determined by chest
X-ray and group 3 (G3, n=4) seropositive patients had ECG
abnormalities, heart enlargement and clinical or radiologic
evidence of heart failure. Patients had not received treatment for
T. cruzi at the time of sample collection.
The uninfected control group (n=10) consisted of age-matched
Caucasian of areas where T. cruzi was not endemic who were
found to be negative for T. cruzi by serologic testing. T. cruzi-
infected subjects and uninfected controls with hypertension,
ischemic heart disease, cancer, HIV infection, syphilis, diabetes,
arthritis or serious allergies were excluded from this study. This
study was approved by the Institutional Review Boards of the
Hospital Interzonal General de Agudos ‘‘Eva Pero ´n’’ Buenos
Aires, Argentina and the University of Georgia, Athens, GA, USA.
Collection of peripheral blood mononuclear cells
(PBMCs)
Approximately 50 ml of blood were drawn by venipuncture into
heparinized tubes (Vacutainer, Becton-Dickinson, San Jose ´, CA).
PBMC were isolated by density gradient centrifugation on
Lymphocyte Separation Medium (ICN, Ohio,OH) and resus-
pended in RPMI (Mediatech, Herndon, VA) supplemented with
10% heat-inactivated FCS (Hyclone Laboratories, Logan, UT).
Peptides
HLA supertype binding affinity predictions were performed
computationally [27] on ts proteins using the raw T. cruzi genome
sequencing reads (T. cruzi Genome Sequencing Consortium). Nine
to 10 aa-length peptides were synthesized by Pepscan Systems
Author Summary
At present, 16–20 million people in Central and South
America are infected with Trypanosoma cruzi, the causative
agent of Chagas disease in humans. The primary clinical
consequence of the infection is a cardiomyopathy, which
manifests in approximately 30% of infected individuals,
many years after the initial infection. Our work in Chagas
disease patients began as an effort to assess the range and
specificity of antigens that were recognized by T cells, in
particular CD8
+ T cells, in individuals with long-term
infections with Trypanosoma cruzi. Trans-sialidase proteins
from T. cruzi are major surface and released proteins that
are targets of humoral and cellular immune responses. We
previously, identified a set of trans-sialidase peptides that
were recognized by a very low frequency of chronically T.
cruzi-infected subjects. Based on bioinformatic predictions,
herein we report the identification of new trans-sialidase
epitopes that are recognized by a higher proportion of T.
cruzi-infected people. The functional profile of T cells
specific for these peptides is characteristic of an infection
with long term stimulation of the immune system, with
high levels of IFN-c-secreting T cells and low levels of IL-2
production. This set of T. cruzi peptides should prove
useful for monitoring immune competence and changes in
infection and disease status in individuals with chronic
Chagas disease.
HLA Class I Supertype T Cell Responses
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10–20 mg/ml in DMSO, aliquoted and stored at 220uC.
T. cruzi lysate
Protein lysate from T. cruzi amastigotes was obtained by 4
freeze/thaw cycles followed by sonication as previously reported
[7]. Briefly, trypomastigotes from Brazil strain were cultured
overnight in pH 5 DMEM (Mediatech) to transform trypomasti-
gotes to amastigotes. After washing, the parasites were frozen at
220uC and thawed twice. Thereafter, the sample was subjected to
2 freeze/thaw cycles at 270uC followed by sonication. The
supernatant of a 12000 rpm centrifugation was collected, filter-
sterilized and the protein concentration determined.
HLA-A0201 typing
HLA-A0201 typing was performed as previously described [7]
by incubating 1610
6 PBMC with HLA-A2.1-specific mAB BB7.2
[32] (10 mg/ml; American Type Culture Collection, Bethesda,
MD) for 30 min at 4uC, followed by FITC-labelled F(ab’)2 goat
anti-mouse IgG (1/50 dilution; Immunotech, Marseille, France).
Positive fluorescence indicating expression of HLA-A2.1 was
assessed by analysis of cells using fluorescence microscopy.
HLA-A class I binding assays
The binding affinity of synthetic peptides for HLA class I
molecules was quantified by measuring their ability to competi-
tively inhibit the binding of a radiolabeled standard probe peptide
to purified detergent-solubilized HLA-A2.1 molecule, as previous-
ly described [27,32].
IFN-c and IL-2 ELISPOT assays
The number of peptide-specific IFN-c and IL-2-secreting T cells
wasdeterminedbyexvivoELISPOTusingcommercialkits(Becton&
Dickinson, San Diego, CA). Cryopreserved PBMC from chronic
chagasic subjects were seeded in triplicate wells at a concentration of
4610
5/well, and stimulated with individual peptides (10 mg/ml),
peptide pools (7–13 peptides per pool, 5 mg/ml/peptide) comprising
HLA A01 (2 pools), A02 (2 pools), A03 (2 pools), A24 (2 pools), B07
(1 pool) or B44 (1 pool)-binding peptides or T. cruzi lysate (10 mg/ml)
for 16–20 hr at 37uCa n d5 %C O 2. For controls, cells were
incubated with complete RPMI, A2-restricted HIV Pol (amino acids
510–518: ILKEPVHGV), A2-restricted flu matrix 1 (amino acids
58–66: GILGFVFTL) or 50 ng/ml pokeweed mitogen and 500 nM
ionomicin (Sigma). Spot forming cells (SFCs) were automatically
enumerated using ImmunoSpot analyzer (CTL).
The mean number of SFCs in triplicate wells was obtained for
each condition, and the number of specific IFN-c and IL-2-
secreting T cells (net SFCs), was calculated by subtracting the
value of the wells containing media alone from the peptide/
mitogen-stimulated spot count. Responses were considered
significant if a minimum of 25 SFCs/1610
6 PBMC were present
per well, and additionally, this number was at least twice the value
of wells with media alone [33].
Intracellular IFN-c and IL-2 staining
IFN-c and IL-2 production was determined by intracellular
staining after PBMCs isolated from subjects with chronic T. cruzi
infection were stimulated with 15 mg/ml of T. cruzi lysate, 5 mg/ml
of A02-restricted peptide pool or media alone, for 16–20 h. A final
concentration of 10 mg/ml brefeldin A was added for the last 10 h
of incubation. One million PBMCs were stained with anti-CD8
(APC) and anti-CD4 (PerCP) for 30 min at 4uC. The cells were
then fixed and permeabilized with Cytofix/Cytoperm solution
(Becton & Dickinson) for 15 min at 4uC, followed by 2 washes with
Perm/Wash solution (Becton & Dickinson). After washing, the
cells were stained with a FITC-conjugated anti-human IFN-c
(FITC) and IL-2 (PE) for 30 min at 4uC and were analyzed by use
of a FACScalibur (Becton Dickinson Immunocytometry Systems).
Acquisition and analysis of data were performed with CellQuest
software. Typically, 500,000 lymphocytes were collected by gating
on forward-light scatter versus side-light scatter. Data were
reported as percentage of the gated population expressing IFN-c
and IL-2. T-cell responses directed against antigens were
considered positive if the frequency of cytokine-producing T cells
was threefold higher than the frequency with medium alone.
Statistical analysis
Comparisons of the frequencies of responders among the
different clinical groups were evaluated by use of the x
2 test and
Fisher’s exact test. Differences were considered to be statistically
significant at P,0.05.
Results
Identification of promiscuous HLA-A02-restricted
epitopes derived from ts proteins
Based on the frequency of representation in the T. cruzi genome
and HLA-A0201 binding efficiency, we have recently identified a
set of epitope targets of memory CD8
+ T cell responses in chronic
chagasic subjects without manifest cardiac disease [25].
Taking into account that several studies have documented a
correlation between immunogenicity and the capacity to bind
multiple HLA molecules from a given supertype [28,34–37], the
affinity binding of these ts peptides to the other 4 most common
HLA-A02 supertype alleles (A*0201, A*0203, A*0206 and
A*6802) was measured to address whether these ts peptides
displayed degenerate HLA-A2 binding capacity (Table 1). A range
of binding activities was observed for the panel of peptides, from
those that bound only one allele to those exhibiting high binding
for all 5 alleles tested. Overall, a majority of the peptides were
moderately degenerate, with 24 out of the 28 peptides binding 3 or
more HLA-A02-supertype alleles (median6SD=4,11+1,29 pep-
tides bound).
IFN-c ELISPOT responses to MHC I supertype-restricted
epitopes derived from ts proteins
To extend coverage of HLA types in the Chagas disease
population, we next attempted to identify peptides with high
binding affinity for additional HLA class I supertypes. Because our
previous work in a murine model of Chagas disease had shown
that CD8
+ T cell responses were focused heavily on peptides
encoded by multiple ts family genes [25], we restricted our analysis
in humans to ts peptides as well.
HLA supertype binding affinity predictions were performed on
ts sequences using the raw T. cruzi genome sequencing reads,
yielding over 20,000 putative epitopes with a predicted IC50 (50%
inhibitory concentration) of less than 100 nM. Only those peptides
with at least 100 occurrences in the ,1.3 million sequence reads
were further analyzed yielding a total of 1001 epitopes predicted to
bind to HLA A01, A02, A03, A24, B07 or B44 supertypes
(Table 2). The supertype for which the fewest peptides were
predicted was B7, reflecting the fact that this supertype is
associated with a stringent requirement for the relatively
infrequent proline residue in position 2 of its peptide ligands
[26]. At the other end of the spectrum, A2 and A3 supertypes have
the largest number of peptides, reflecting the relative commonality
of the residues associated with these motifs (Table 2).
HLA Class I Supertype T Cell Responses
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binding epitopes was then used to prioritize peptides to be assessed
for recognition by CD8
+ T cells from a group of non-HLA-typed
chagasic subjects (Table 2). IFN-c ELISPOT responses to peptide
pools containing a total of ninety-six epitopes representing HLA
A01 (18 epitopes), HLA A02 (20 epitopes), HLA A03 (20 epitopes),
HLA A24 (14 epitopes), HLA B07 (11 epitopes) and HLA-B44 (13
epitopes) supertypes were evaluated in 25 chronic Chagas disease
subjects without clinical and radiological evidence of heart disease
(G0 status) regardless of their HLA type. Thirteen out of 25 (52%)
subjects showed positive responses to supertype-restricted ts-
sialidase peptides ranging in magnitude from 15 to 500 T. cruzi-
specific SFCs/10
6 (SFCs in media alone subtracted, Table 2). Four
subjects had positive responses to more than one supertype (3 of
these subjects recognized both HLA-A02 and HLA-A03-binding
peptides, Fig. 1). It is noteworthy that responses to HLA-A02 and
HLA03 supertype-restricted epitopes covered 77% of the total
responses detected, consistent with the high worldwide frequency
of these alleles [26].
As a positive control for the ability of T cells to respond to
parasite antigens, the response to an amastigote lysate preparation
which has been previously shown to activate both CD4
+ and
CD8
+ T cell subsets in T. cruzi-infected mice [22] and subjects [7]
was also measured. Twenty out of the 25 (80%) patients evaluated
displayed positive responses to the lysate with 11 subjects
responding to both the T. cruzi lysate and ts-derived peptides.
Table 1. CD8
+ T cell responses specific for ts-derived peptides with high representation in the T. cruzi genome in HLA-A2.1
+
patients with chronic Chagas disease, measured by IFN-c ELISPOT.
Peptide
(A) Sequence Nu genes
(B) Nuproteins
(C) A2.1-binding
No. of positive responders/total no. of subjects
assayed (%)
(IC 50 nM) (D) G0 G1 G2/G3
Ts 48 FANYNFTLV 253 51 0.47 (5) 3/10 (30) 0/7 1/14 (7)
Ts 3 GLLPSLLLLL 104 23 3.1 (4) 4/11 (36) 0/9 0/14
Ts 13 LLGLWGTAAL 63 14 499 (3) 2/9 (22) 0/6 1/15 (7)
Ts 2 LLGLWVFAAL 46 8 36 (4) 4/10 (40) 0/8 1/16 (6)
Ts 46 FANHNFTLV 39 6 119 (5) 3/11 (27) 1/8 (13) 1/14 (7)
Ts 44 FANYKFTLV 36 9 49 (5) 7/15 (47) 2/12 (17) 1/17 (6)
Ts 43 FANNKFTLV 36 17 116 (5) 2/9 (22) 0/6 1/11 (9)
Ts 58 RVSRPTTVV 32 5 2487 (2) 0/6 0/5 0/8
Ts 66 DVSRPTAVV 21 7 .50000 (1) 3/7 (43) 1/6 (17) 0/9
Ts 37 FVNHRFTLV 18 6 304 (5) 6/11 (44) 2/9 (22) 2/17 (12)
Ts 51 FANYNFTLL 17 2 1499 (2) 0/7 0/5 0/10
Ts 52 ELLRPTTLV 16 6 2407 (1) 1/7 (14) 0/5 0/10
Ts 49 FANNEFTLV 13 5 47 (5) 5/11 (45) 1/9 (11) 2/15 (13)
Ts 68 FTNNKFTLS 12 0 .50000 (3) 0/6 0/5 0/8
Ts 38 FANHKFTLV 10 4 148 (4) 5/16 (31) 2/12 (17) 2/17 (12)
Ts 35 FVSCDFTIV 10 0 30 (5) 6/16 (38) 3/11 (27) 2/16 (13)
Ts 24 FLSHDFTLV 7 4 0.46 (4) 4/10 (40) 0/8 1/15 (7)
Ts 6 LLGLWGLATA 7 4 24 (5) 0/9 0/6 2/13 (15)
Ts 4 RLLPSLLLLL 7 2 0.80 (4) 1/10 (10) 0/6 1/14 (7)
Ts 28 FVNYDFALV 6 0 79 (5) 4/11 (36) 0/8 2/15 (13)
Ts 32 FANCNFTLV 5 1 79 (5) 5/15 (33) 0/11 2/16 (12)
Ts 50 FVNYDFTIV 3 0 77 (5) 2/9 (22) 0/6 1/13 (8)
Ts 47 FVDYNFSLV 3 0 1.1 (5) 2/9 (22) 0/6 1/12 (8)
Ts 45 FVNYNFTLV 2 1 0.25 (5) 3/13 (23) 1/9 (11) 1/15 (7)
Ts 56 IANYNFTLV 1 0 29640 (3) 1/6 (17) 1/4 (25) 0/9
Ts 27 FLSHNFTLVF 0 0 0.61 (5) 2/9 (22) 1/6 (17) 1/14 (7)
Ts 26 SLSHYFTLVF 0 0 1.6 (5) 5/15 (33) 1/11 (9) 1/17 (6)
Ts 34 FANHDFTLV 0 0 101 (5) 2/9 (22) 1/6 (17) 1/13 (8)
Total no. of responders 9/15*(60) 5/12 (42) 4/18 (22)
Mean net SFCs6SD /10
6 PBMC in peptide-stimulated wells
(E) 1206185 1206105 100645
Mean SFCs6SD/10
6 PBMC in media alone 18616 23628 18626
(A)All the peptides assayed were recognized by spleen cells from T. cruzi-infected A2 transgenic mice (25).
(B)Number of annotated T. cruzi genes containing indicated epitopes (13).
(C)Number of proteins containing indicated epitopes identified in T. cruzi proteome (59).
(D)Number of alleles of the HLA-A2 supertype bound.
(E)Mean values was obtained from responders subjects. (
*) P=0.04 vs. G2/G3 (Fisher’s exact test).
doi:10.1371/journal.pntd.0000288.t001
HLA Class I Supertype T Cell Responses
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responses to the amastigote lysate denoting the overall low T. cruzi-
specific T cell responses in these individuals.
Next, selected positive peptide pools were deconvoluted to
identify the individual peptides responsible for the activity detected
within the pool. Stimulation of PBMC from 12 of the responder
subjects with single peptides revealed a total of 27 distinct epitopes
(1 HLA-A01, 16 HLA-A02 and 10 HLA-A03-binding peptides) as
target epitopes (Table 3). Because of limitations of sample
availability and the low number of subjects responsive to the
A24, B07 and B44-binding peptide pools, the individual target
epitopes for these supertypes were not determined.
The nature of a T cell response to complexes formed by
peptides with major histocompatibility proteins can be greatly
affected by variations in the peptide’s amino acid sequence
[38,39]. Some peptides (agonists) elicit the full range of known
responses; others (partial agonists), often differing from agonists by
only one or a few amino acid residues, elicit partial responses;
while others (antagonist peptides) inhibit the activity of agonists.
To rule out the possibility that pooling peptides might influence
ELISPOT responses, PBMC from 9 non-responder subjects to
pooled peptides were assayed with individual peptides. We found
positive responses in only one subject with previous negative
responses to pooled peptides demonstrating that pooling peptides
had a minimal effect on detection of T cell responses.
Altogether, a hierarchy of antigenicity was apparent with the
A02 supertype peptides being the most frequently recognized in
the Chagas disease population followed by the A03 and the A24
supertype peptides. This analysis also allowed the identification of
previously unknown ts epitopes that may be useful for the
monitoring CD8
+ T cell responses in Chagas disease subjects
regardless of their HLA type.
IFN-c and IL-2 ELISPOT responses to ts-derived HLA-
A201-binding peptides in HLA-A201
+ T. cruzi chronically
infected subjects with different degrees of cardiac
dysfunction
The degenerate A02 peptides identified above were used to
examine correlations between disease severity and CD8
+ T cells
responses in chronically T. cruzi-infected subjects. PBMCs from
HLA-A201-positive T. cruzi-infected and uninfected individuals
were tested for IFN-c secretion in response to 28 individual HLA-
A0201-binding peptides, showing 60% of individuals (9/15) in G0
responding and 22% of the patients (4/18) in G2–G3 responding
to ts peptides (Table 1). The uninfected control group did not show
positive responses to HLA-A02-binding peptides assessed in pools
or separately (mean net SFCs6SD /10
6 PBMC in peptide-
stimulated wells=1.5262.01; mean SFCs6SD /10
6 PBMC in
media alone=4.9 064.03). These results confirm our previous
findings demonstrating that individuals with more severe disease
had relatively poor T cell responses to whole parasite lysates [7].
Although quantitative measures of T-cell function assessed by
IFN-c secretion have been proven to be a valuable tool for
monitoring disease activity in various human infections, the
measurement of other T-cell functions, such as IL-2 secretion,
proliferation capacity and cytotoxic activity is also informative
[40]. To further characterize the function of T. cruzi-specific T
cells in subjects with chronic Chagas disease, IFN-c and IL-2
secretion were simultaneously measured by ELISPOT after
stimulation with 4 to 15 individual HLA-A0201- binding ts
peptides or with a T. cruzi amastigote lysate preparation. Positive
IL-2 responses were very low irrespective of the clinical status of
the subjects, and was essentially undetectable in the G1 group
upon stimulation with ts peptides (mean net SFCs6SD/10
6
PBMC in subjects with positive IL-2 ELISPOT responses=2868,
range=15–55; mean SFCs6SD/10
6 PBMC in media
alone=665), [Fig. 2A]. Less than 30% of the individuals
evaluated displayed positive IL-2 and IFN-c ELISPOT responses
while IL-2 responses alone was not detected (Fig. 2A).
Low IL-2 production was not confined to the CD8
+ T cell
compartment as stimulation with a T. cruzi lysate, which had been
previously shown to induce both CD4
+ T and CD8
+ T cell
responses [7,22] also failed to induce IL-2 secretion (mean net
SFCs6SD/10
6 PBMC in subjects with positive IL-2 ELISPOT
responses=65650, range=25–153) [Fig. 2A]. In contrast,
responses to influenza in subjects belonging to this same cohort
showed a more functional response with 10 out of 15 responders to
an A2-restricted Flu peptide producing both IFN-c and IL-2 or IL-
2 alone while the remaining 5 produced only IFN-c ELISPOT
responses (data not shown).
In order to determine if IFN-c and IL-2- double-secreting T cells
were present in these subjects, intracellular cytokine staining assays
were performed with PBMC from 5 subjects with positive IL-2 and
IFN-cELISPOTresponsestoT.cruziantigens.Inoneindividual,the
recall T cell responses to the lysate were mainly composed of two
functionally distinct populations, single IFN-c-secreting and single
IL-2-secreting T cells while in the 4 remaining individuals dual IFN-
c/IL-2-secreting cells and a larger set of single IFN-c-secreting T
cells was observed upon stimulation with a pool of HLA-A02-
binding peptides (Fig. 2B) or a T. cruzi lysate (Fig. 2C).
This functional pattern of cytokine production in response to
HLA-class I-restricted ts epitopes in conjunction with the negative
correlation between disease severity and IFN-c-secreting T cells,
found in the present and former studies [7], as well the increased
levels of fully differentiated T cells in these patients [8] supports
the notion that the long-term persistence of T. cruzi infection may
lead to a degradation of parasite-specific T cell responses.
Discussion
Antigen-specific CD8
+ T cells are crucial components of the
immune response against a large number of pathogens, including
Trypanosoma cruzi [21]. In human viral infections, reproducible
measures of T cell function has led to the identification of
functional signatures associated with disease control that are useful
for the monitoring of disease activity [41–43] contrasting with the
Table 2. T. cruzi-specific IFN-c ELISPOT responses to ts-
derived peptides restricted by MHC class I supertypes.
Class I
supertype (*)
Predicted no.
of peptides
No. of positive
responders/total no. of
subjects evaluated (%)
Net SFCs per
10
6 PBMC (#)
HLA A01 116 2/25 (8) 25–50
HLA A02 451 7/25 (28) 15–500
HLA A03 287 6/25 (24) 25–53
HLA A24 100 4/25 (16) 18–40
HLA B07 20 2/25 (8) 15–18
HLA B44 27 2/25 (8) 20–25
Total 1001 13/25 (52)
(
*) Peripheral blood mononuclear cells were stimulated with pooled peptides
from each HLA-type; SFC: spot forming colony; (#) The number of spots from
wells containing media alone was subtracted from the peptide-stimulated spot
count, mean SFCs6SD/10
6 PBMC in media alone=9612.
doi:10.1371/journal.pntd.0000288.t002
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www.plosntds.org 5 September 2008 | Volume 2 | Issue 9 | e288Figure 1. IFN-c ELISPOT responses to ts proteins of T. cruzi restricted by class I HLA supertypes. PBMC from chronic Chagas disease
subjects were stimulated in bulk with HLA-A01, HLA-A02, HLA-A03, HLA-A24, HLA-B07 and HLA-B44 supertype ts peptide pools, T. cruzi lysate (Ly) or
media (Me) alone and tested for IFN-c secretion as described in the Materials and Methods. Representative positive responses for single subjects are
shown. (*) Indicates positive responses as defined in the Materials and Methods.
doi:10.1371/journal.pntd.0000288.g001
HLA Class I Supertype T Cell Responses
www.plosntds.org 6 September 2008 | Volume 2 | Issue 9 | e288situation in human parasitic infections, mainly because of the
difficulty in detecting the epitope specificity of CD8
+ T cells in
these chronic infections [7,22,24,33,44].
Previous studies of chronic chagasic subjects have shown that
the frequency of T. cruzi-specific T cells recognizing HLA-A0201-
restricted peptides from ts-sialidase, LYT-1 and calcium binding-
proteins of T. cruzi was extremely low [7]. The prior analysis was
restricted to HLA-A201-binding epitopes because of the high
frequency of expression of this allele in individuals of various
ethnic backgrounds [45,46], including those living in areas of
Latin America where Chagas disease is endemic [47], and thus the
relative ease with which HLA-A201 expressing individuals can be
identified. More recently, we applied a new strategy for the
selection of potential epitopes target of CD8
+ T cell responses in T.
cruzi infection, based on both the high binding capacity for the
HLA-A0201 allele and the high frequency of representation in the
T. cruzi genome as the abundance of the source gene product
appears to have a major contribution in immunodominance [48].
Even though HLA-A201 is expressed by ,30% of individuals,
this still leaves the majority of T. cruzi-infected subjects inaccessible
to study T cell responses using defined CD8
+ T cell epitopes. To
extend the coverage of the patient population regardless of HLA
type, herein we have focused on the identification of potentially
immunogenic ts epitopes that bind to more than one MHC allele
of the six most common HLA class I supertypes based on HLA-
supertype binding predictions. The relatively high number of
predicted epitopes for non-A02 supertypes was surprising
considering that proteins ‘‘degenerate’’ for one supertype, are
unlikely to also be degenerate for other HLA supertypes [28]. We
show that promiscuous ts HLA-A02, HLA-A03 and HLA A24-
binding epitopes are primary targets of memory CD8
+ T cell
responses in chronic Chagas disease patients, detecting responses
in 13 out of 25 G0 subjects being the hierarchy in the antigenicity
well correlated with the number of epitopes identified for these
HLA supertypes. These results provide a specific set of class I
MHC restricted peptides with which we can measure the
frequency and functional activity of T. cruzi-specific CD8
+ T cells
in T. cruzi-infected individuals regardless of their HLA type.
In a previous study, we showed that 9 out of 10 (90%)
asymptomatic (G0 clinical status) chronically infected subjects
display positive CD8
+ T cell responses to autologous T. cruzi-
infected dendritic cells [8] while the use of an amastigote lysate
preparation revealed CD8
+ T cell responses in 6 out of 8 (75%) G0
subjects evaluated [7]. Even though we are testing only a fraction
of all the potential class I-restricted CD8
+ T cell epitopes herein, it
is of significance that over one-half of the subjects evaluated
displayed positive responses to peptides encoded by a single T.
cruzi protein family, further supporting the immunodominant
nature of ts gene products.
However, the pattern of recognition in subjects with chronic T.
cruzi infections contrasts with the extremely strong and highly
focused response to a few ts epitopes observed throughout T. cruzi
infection in mice [25]. Similarly, anti-vaccinia responses in
humans are distributed among several different determinants
while a single epitope accounts for nearly one quarter of the total
anti-vaccinia response in mice [49,50]. Therefore, human
responses against large complex pathogens are often multispecific
and broad [10,11]. A number of factors probably contribute to the
greater variability of immunodominance hierarchies to ts epitopes
in human infection with T. cruzi, including strain variance in ts
genes, the influence of exposure to other infections [12,51],
heterozygocity in MHC genes and exhaustion of T-cell responses
as a consequence of chronic antigen persistence [52–55].
Few reports have addressed the identification of targets of CD8
+
T cells in the chronic phase of human T. cruzi infection
[7,24,25,56]. CD8
+ T cell responses to HLA-A0201-restricted
epitopes from the T. cruzi proteins cruzipain and FL-160 have
been reported in a small group of chronically T. cruzi-infected
individuals living in non endemic areas [24] and an HLA-A0201-
binding peptide encoded by the kinetoplastid membrane 11
protein (KMP-11) has been shown to be the target of T cell
responses in subjects living in areas endemic for T. cruzi [56].
Although comparison of epitopes from other proteins in the
context of different human MHC class I alleles might allow
further identification of bona fide dominant epitopes, the
present study shows a useful approach to identify epitopes in
complex pathogens like T. cruzi that are recognized by T cells
restricted by different human class I alleles. This approach may be
particularly useful in light of the recent demonstration of HLA
promiscuity, i.e. that epitope presentation and CTL recognition in
HIV-infected individuals may occur frequently in the context of
alternative HLA class I alleles, with responses being detected in
individuals not expressing the originally described restricting HLA
allele [29].
Table 3. Summary of identified A1, A2 and A3 supertype
epitopes.
Peptide sequence HLA allele No. Net IFN-c SFCs/10
6 PBMC (*)
VTDNNRSFY A1 30
LWLTDNTHI A2 463
LLLGLWGFA A2 30
YNFTLVATV A2 22
FTSAVLLLL A2 25
MLVTLPVYS A2 15
NVMLVTLPV A2 18
FVSPSLVSA A2 18
ALSSSLGNV A2 22
HLFYSAVLL A2 40
FLYNRPLNS A2 18
HNFTLVASV A2 15
LLLLVVMMCC A2 18
TSAVLLLLVV A2 18
SIPTAGLVAV A2 22
FQGAWAEWPV A2 32
RVLLLLLLGL A2 20
MLSRVAAVK A3 38
FTLVATVSI A3 70
FTLVASVTI A3 35
AVAEAQCKK A3 18
VALMLQGNK A3 18
LVTLPVYSK A3 15
DVAASSLLY A3 13
ITATIEGRK A3 50
IYMLVGKYS A3 65
GVIAAFAEGH A3 22
(*)Representative results from single individuals are shown.
Net responses were calculated by subtracting the value of the wells containing
media alone from the peptide-stimulated spot count; mean SFCs6SD/10
6
PBMC in media alone=13610.
doi:10.1371/journal.pntd.0000288.t003
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CD4
+ T cells was not specifically addressed in the present study,
the short 9 mer peptides used would unlikely be capable of binding
class II MHC molecules. Of note, PBMC stimulated with ts
epitopes did not induce IFN-g secretion by CD4
+ T cells as
determined by intracellular staining assays (data not shown).
Moreover, in former studies, we confirmed that the IFN-g-
producing T cells upon stimulation with HLA-A0201-binding
peptides belonged to the CD8
+ T cell compartment, as depletion
of CD8
+ T cells abolished the secretion of IFN-c by PBMC [7] and
staining with MHC class I tetramers detected CD8
+ T cells specific
for ts epitopes [25].
Figure 2. Analysis of functionally distinct populations of T. cruzi-specific T cells in HLA-0201
+ chronic Chagas disease patients. PBMC
from G0, G1 and G2/G3 patient groups were stimulated with 4 to 15 individual HLA-A0201-binding ts peptides (top) or with T. cruzi lysate (bottom)
and tested for IFN-c and IL-2 secretion by ELISPOT. The number of subjects with positive IFN-c (black bars) or IFN-c and IL-2 (hatched bars) ELISPOT
responses out of the total evaluated ( percentage of responder subjects) is shown. (*) P=0.035 vs G2/G3 (Fisher’s Exact test) (A). Flow cytometry
profiles of the distribution of IFN-c and IL-2-secreting T cell populations. One representative profile is shown for CD8
+ (B) and CD4
+ (C) T cell
responses after stimulation with ts peptides or T. cruzi lysate, respectively.
doi:10.1371/journal.pntd.0000288.g002
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and IL-2 production profiles of T cells specific for ts epitopes from
individuals at different clinical stages of chronic Chagas disease. A
novel finding of our study is that subjects with chronic T. cruzi
infection display a low prevalence of IL-2-secreting CD8
+ and also
CD4
+ (as determined by stimulation with an amastigote lysate
preparation) T cells specific for T. cruzi. Remarkably, the severe
depletion of IL-2-secreting T cells was confined to those specific
for T. cruzi, as higher frequencies of IL-2-secreting CD8
+ T cells
specific for influenza, a viral infection associated with antigen
clearance, was found in these patients.
The presence of IL-2- and dual IL-2/IFN-c-secreting CD4
+
and CD8
+ T cells has been associated with protracted antigen
exposure and persistence with low antigen load and high
proliferative capacity while IFN-c-secreting T cells were associated
with antigen persistence with high antigen load and poor
proliferative capacity [41–43]. However, since in T. cruzi infection
parasite load is extremely low in chronically infected individuals,
the long-term parasite persistence rather than the high parasite
load is likely to be responsible for driving the parasite specific T
cell population to monofunctional IFN-c-T cells with low self-
renewal capacity.
In a mice model of chronic infection with the lymphocytic
choriomeningitis virus, a hierarchical loss of different T-cell
functions has been proposed with the production of IL-2 being the
first function compromised followed by the ability to make tumor
necrosis factor alpha, while IFN-c production was most resistant to
functional exhaustion [52]. Impaired IL-2 production is one of the
main features of senescent T cells that lead to impaired
proliferative capacity and decreased responsiveness to TCR
stimulation as observed during aging [54,57]. The loss of CD28
on CD8
+ memory T cells found in chronic Chagas disease patients
[8] is in agreement with the low levels of IL-2 secreting memory T
cells since CD28 is essential for delivery of the second activation
signal to T cells that leads to IL-2 gene transcription [58].
Moreover, CD4
+ T cells producing IL-2 are also impaired in
Chagas disease patients further compromising the T cell function
in these patients.
This cytokine pattern of T. cruzi-specific CD8
+ T cells along
with the inverse correlation between IFN-c responses and disease
severity is in agreement with the phenotypic profile formerly found
in this same cohort of patients in which the proportion of fully
differentiated memory (CD45RA
2CD27
22CD28
22) CD8
+ T
cells in the total memory CD8
+ T cell population increases as
disease becomes more severe [8]. We have also recently found that
IFN-c-secreting CD4
+ T cells specific for T. cruzi are enriched in
CCR7
2CD122
2CD127
2 cells (Pe ´rez et al., unpublished data)
characteristic of long-term antigen stimulation.
As a whole, from these data we hypothesize that chronic
stimulation with T. cruzi might lead to distinct stages of functional
impairment and eventually to physical deletion of parasite-specific
T cells, probably affecting the ability of the immune system to
efficiently control the infection in these subjects with the possible
consequence of accelerated disease progression.
We cannot rule out the possibility that the reduced T cell
function observed in patients with advanced cardiomyopathy and
heart failure may be a consequence of the heart failure itself rather
than immunological attrition, although we are not aware of any
mechanism that could account for such association. The
monitoring of T cell responses during the natural course of T.
cruzi infection would be required to further clarified this issue. We
have mainly focused our study on T. cruzi-infected individuals
without signs of heart disease in order to start building a map of T
cell recognition and functionality in individuals capable of
controlling the infection, thereby providing insight into what
constitutes an effective immune response in T. cruzi infection,
The set of class I MHC restricted peptides identified herein will
be useful for the measurement of the frequency and functional
activity of T. cruzi-specific CD8
+ T cells in T. cruzi-infected
individuals and should facilitate the monitoring of immune
competence and changes in infection and disease status in
individuals with chronic Chagas disease.
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